|
市場調査レポート
商品コード
1458099
体外受精の世界市場規模、シェア、成長分析、製品タイプ別、最終用途別 - 産業予測、2024年～2031年Global In Vitro Fertilization Market Size, Share, Growth Analysis, By Product Type(Fresh Donor, Fresh Non-Donor), By End-use(Fertility Clinics, Surgical Centers) - Industry Forecast 2024-2031 |
||||||
|
|
|||||||
| 体外受精の世界市場規模、シェア、成長分析、製品タイプ別、最終用途別 - 産業予測、2024年～2031年 |
|
出版日: 2024年03月29日
発行: SkyQuest
ページ情報: 英文 219 Pages
納期: 3～5営業日
|
- 全表示
- 概要
- 目次
体外受精の世界市場規模は2022年に237億5,000万米ドルと評価され、予測期間（2024年～2031年）のCAGRは5.7%で、2023年の251億米ドルから2031年には391億1,000万米ドルに成長する見通しです。
体外で精子と卵子を受精させる生殖補助医療（ART）市場は、体外受精の世界市場として知られています。体外受精は現在、不妊症を治療し、カップルが妊娠するのを助けるために一般的に使用されている技術です。体外受精には、受精、採卵、卵巣刺激、胚移植といった多くのプロセスが含まれます。体外受精の主な目的は、妊娠に問題を抱えているカップルを支援し、健康な妊娠を実現する手段を提供することです。自然妊娠が不可能、または成功する見込みがない場合、体外受精（IVF）が利用されます。この市場は、親になりたいと願いながらも不妊に悩む個人やカップルに解決策を提供しています。様々な病気、妊娠の遅れ、ライフスタイルの変化、ホルモンバランスの乱れなどが原因で、世界中で不妊症の発生率が増加しています。体外受精（IVF）の成功率は、実験室技術、凍結保存技術、遺伝子検査、胚選択などの技術開発により飛躍的に向上しました。信頼性が高く、成功率の高い生殖医療を求めるカップルは、このような技術開発に惹かれています。体外受精治療を受けるカップルは、心理的にも肉体的にも困難な旅路に直面することが多いです。特定の個人やカップルにとっては、激しい治療レジメン、未知の成功率、心理的な負担が、体外受精を追求する障害となるかもしれないです。生殖医療へのアクセスと利用可能な選択肢に関する知識が拡大しつつある発展途上国では、体外受精の需要が高まっています。このため、こうした地域での体外受精施設の開拓や市場拡大の可能性があります。その可能性とは、発展途上国からの需要の高まりや、患者の治療成績や成功率を高める技術の進歩などです。新しい方法と戦略が開発されるにつれ、体外受精産業は変化を続け、家族を作ったり増やしたいと考えているカップルに選択肢と希望を与えています。
目次
エグゼクティブサマリー
- 市場概要
- 運命の輪
調査手法
- 情報調達
- セカンダリおよびプライマリデータソース
- 市場規模の推定
- 市場の前提条件と制限
親市場の分析
- 市場概要
- 市場規模
- 市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
主な市場の考察
- 技術分析
- 価格分析
- サプライチェーン分析
- バリューチェーン分析
- 市場のエコシステム
- IP分析
- 貿易分析
- スタートアップ分析
- 原材料の分析
- イノベーションマトリクス
- パイプライン製品の分析
- マクロ経済指標
- 主な投資の分析
- 主な成功要因
- 競合の程度
市場力学と見通し
- 市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
- 規制情勢
- ポーターの分析
- 将来の混乱についての特別な考察
体外受精の世界市場：製品タイプ別
- 市場概要
- 新鮮ドナー
- 新鮮非ドナー
- 凍結ドナー
- 凍結非ドナー
体外受精の世界市場：最終用途別
- 市場概要
- 不妊治療クリニック
- 外科センター
- 病院
- 研究機関
体外受精の世界市場規模：地域別
- 市場概要
- 北米
- 米国
- カナダ
- 欧州
- ドイツ
- スペイン
- フランス
- 英国
- その他の欧州
- アジア太平洋
- 中国
- インド
- 日本
- 韓国
- その他のアジア太平洋
- ラテンアメリカ
- ブラジル
- その他のラテンアメリカ
- 中東・アフリカ（MEA）
- GCC諸国
- 南アフリカ
- その他の中東・アフリカ
競合情勢
- 上位5社の比較
- 主要企業の市場ポジショニング（2021年）
- 主な市場企業が採用した戦略
- 主要成功戦略
- 市場における最近の活動
- 主要企業の市場シェア（2021年）
主要企業プロファイル
- CooperSurgical, Inc.（US）
- Vitrolife AB（Sweden）
- Cook Medical（US）
- Irvine Scientific（US）
- Merck KGaA（Germany）
- Thermo Fisher Scientific, Inc.（US）
- Esco Micro Pte Ltd（Singapore）
- Genea Limited（Australia）
- Ferring Pharmaceuticals（Switzerland）
- Hamilton Thorne, Inc.（Canada）
- Nidacon International AB（Sweden）
- Rocket Medical plc（UK）
- EMD Serono（US）
- OvaScience（US）
- Kitazato Corporation（Japan）
- IVFtech Aps（Denmark）
- Zeiss Group（Germany）
- Igenomix（Spain）
- Labotect GmbH（Germany）
- Esco Medical（Singapore）
Global In Vitro Fertilization Market size was valued at USD 23.75 Billion in 2022 and is poised to grow from USD 25.10 Billion in 2023 to USD 39.11 Billion by 2031, at a CAGR of 5.7% during the forecast period (2024-2031).
The market for assisted reproductive technology (ART) treatments that entail fertilizing an egg with sperm outside of the human body is known as the global in vitro fertilization market. IVF is now a commonly used technique to treat infertility and help couples become pregnant. It includes a number of processes like fertilization, extraction of eggs, ovarian stimulation, and embryo transfer. The main goal of the IVF industry is to assist couples who are having trouble conceiving and provide them with a means of achieving a healthy pregnancy. When natural pregnancy is either impossible or unlikely to succeed, in vitro fertilization (IVF) is utilized. The market offers solutions to individuals and couples who want to become parents but are struggling with infertility. The incidence of infertility around the world have been increasing as a result of various diseases, delayed pregnancies, altered lifestyles, and hormonal imbalances. Success rates in in vitro fertilization (IVF) have increased dramatically due to technological developments in laboratory techniques, cryopreservation technologies, genetic testing, and embryo selection. Couples looking for dependable and successful reproductive treatments are drawn to these developments. Couples undergoing IVF therapy frequently face a difficult psychological and physical journey. For certain individuals or couples, the intense treatment regimen, unknown success rates, and psychological strain may serve as obstacles to pursuing in vitro fertilization. In developing nations, where access to reproductive treatments and knowledge of available options are expanding, there is a growing demand for IVF procedures. This offers chances for the development of IVF facilities in these areas and market expansion. Possibilities include the rising demand from developing nations and technology advancements that can enhance patient outcomes and success rates. As new methods and strategies are developed, the IVF industry keeps changing, giving couples looking to start or grow a family options and hope.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global In Vitro Fertilization Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global In Vitro Fertilization Market Segmental Analysis
The product, end-use, and geographic segments of the worldwide in vitro fertilization market are split up. The market is divided into four categories based on product: frozen donor, frozen non-donor, fresh donor, and fresh non-donor. Hospitals, surgery centers, research institutes, and fertility clinics make up the various end-user segments of the market. The market is divided into five regions: Latin America, Middle East and Africa, Asia Pacific, Europe, and North America.
Drivers of the Global In Vitro Fertilization Market
Significant improvements in the reproductive technologies utilized in IVF operations were made in 2021. Time-lapse imaging techniques, for example, have made it possible to continuously watch the growth of embryos, which has improved selection and increased success rates. More people and couples chose to undertake IVF treatments as a result of these developments.
Restraints in the Global In Vitro Fertilization Market
In 2021, the expense of IVF procedures continued to be a major barrier. Many individuals and couples find IVF unaffordable due to the high costs of medication, laboratory procedures, and several treatment cycles. This is especially true for those who lack sufficient financial resources or insurance coverage.
Market Trends of the Global In Vitro Fertilization Market
Growing Trend in Genetic Testing: Preimplantation genetic testing (PGT) and other genetic testing methods were becoming more and more popular in IVF treatments in 2022. By enabling the screening of embryos for genetic abnormalities prior to implantation, PGT lowers the risk of genetic problems in kids and increases the likelihood of successful pregnancies.
Growing Emphasis on Personalized Medicine: In the IVF industry, personalized medicine became more well-known in 2021. The strategy entails customizing IVF treatment plans according to the unique characteristics of each patient, including age, ovarian reserve, and unique reproductive issues. The goal of personalized medicine is to increase the effectiveness of IVF treatments and maximize treatment results.
Table of Contents
Executive Summary
- Market Overview
- Wheel of Fortune
Research Methodology
- Information Procurement
- Secondary & Primary Data Sources
- Market Size Estimation
- Market Assumptions & Limitations
Parent Market Analysis
- Market Overview
- Market Size
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Key Market Insights
- Technology Analysis
- Pricing Analysis
- Supply Chain Analysis
- Value Chain Analysis
- Ecosystem of the Market
- IP Analysis
- Trade Analysis
- Startup Analysis
- Raw Material Analysis
- Innovation Matrix
- Pipeline Product Analysis
- Macroeconomic Indicators
- Top Investment Analysis
- Key Success Factor
- Degree of Competition
Market Dynamics & Outlook
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
- Regulatory Landscape
- Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
- Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Global In Vitro Fertilization Market by Product Type
- Market Overview
- Fresh Donor
- Fresh Non-Donor
- Frozen Donor
- and Frozen Non-Donor
Global In Vitro Fertilization Market by End-use
- Market Overview
- Fertility Clinics
- Surgical Centers
- Hospitals
- Research Institutes
Global In Vitro Fertilization Market Size by Region
- Market Overview
- North America
- USA
- Canada
- Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA
Competitive Landscape
- Top 5 Player Comparison
- Market Positioning of Key Players, 2021
- Strategies Adopted by Key Market Players
- Top Winning Strategies
- By Development
- By Company
- By Year
- Recent Activities in the Market
- Key Companies Market Share (%), 2021
Key Company Profiles
- CooperSurgical, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Vitrolife AB (Sweden)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Cook Medical (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Irvine Scientific (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Merck KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Thermo Fisher Scientific, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Esco Micro Pte Ltd (Singapore)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Genea Limited (Australia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Ferring Pharmaceuticals (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Hamilton Thorne, Inc. (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Nidacon International AB (Sweden)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Rocket Medical plc (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- EMD Serono (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- OvaScience (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Kitazato Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- IVFtech Aps (Denmark)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Zeiss Group (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Igenomix (Spain)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Labotect GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Esco Medical (Singapore)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
